HIV Status Disclosure Rate to a Sexual Partner, Associated Factors and Outcomes among Pregnant Women in PMTCT Care in Two Large HIV Facilities in Abuja, Nigeria
HIV status disclosure to partners is critical in improving the health and well-being of mother-infant dyad in the prevention of HIV transmission from mother to child (PMTCT) program. This study assesses the HIV disclosure rate to intimate partners, associated factors, and outcomes among women in the PMTCT program in two large HIV clinics in Abuja, Nigeria. A descriptive cross-sectional study employed a multi-stage sampling technique in selecting 220 pregnant women enrolled in PMTCT care in two clinics. Outcomes measures include HIV status disclosure to intimate partner, women’s viral suppression status (suppressed < 1000 copies/mL, unsuppressed ≥ 1000 copies/mL), and previous MTCT experience. Exposure variables include the participant’s socio-demographic characteristics and HIV care history. Data were presented using frequency tables. Simple and multivariate logistic regression was done to ascertain the predictors of HIV status disclosure and assess the association between HIV disclosure, viral suppression, and MTCT experience at a p-value of less than 0.05. Only 205 (96.7%) entries were completed and analyzed A larger percentage of the participants were married women, 158 (77.1%), within the age group 26 - 35 years (53.3%). Women’s HIV status disclosure rate to intimate partners was 49.3% (101/205). Factors associated with HIV disclosure rate to intimate partners at the univariate level were the participant’s age, Christian religion [COR: 1.80, 95%CI: 1.04 - 3.21, p = 0.04], full employment [COR: 1.92, 95%CI: 1.10 - 3.34, p = 0.02], HIV positivity prior to PMTCT enrollment [COR: 2.88, 95%CI: 1.26 - 6.59, p < 0.01], duration on antiretroviral therapy [COR: 1.07, 95%CI: 1.01 - 1.13, p = 0.03], and knowledge of partner’s HIV status [COR: 0.20, 95%CI: 0.08 - 0.51, p < 0.01]. Only HIV positivity prior to PMTCT enrollment [AOR: 3.27, 95%CI: 1.23 - 8.70, p < 0.01] and awareness of the partner’s HIV status, [AOR: 0.17, 95%CI: 0.06 - 0.49, p < 0.01] were significant predictors of HIV status disclosure after controlling for confounder. The two study outcomes; women’s viral suppression and MTCT experience were not significantly associated with participants’ HIV status disclosure to intimate partners. Our study shows that HIV disclosure to intimate partners is still a big challenge among pregnant women in PMTCT settings in Nigeria, with awareness of the partner’s HIV status and the type of patient enrollment in the PMTCT setting being the two strong predictors of pregnant women’s HIV disclosure status to partners.
References
[1]
Avert (2019) Prevention of Mother-to-Child Transmission (PMTCT) of HIV.
Makin, J.D., Forsyth, B.W., Visser, M.J., Sikkema, K.J., Neufeld, S. and Jeffery, B. (2008) Factors Affecting Disclosure in South African HIV-Positive Pregnant Women. AIDS Patient Care and STDs, 22, 907-916. https://doi.org/10.1089/apc.2007.0194
[4]
Ngonzi, J., Mugyenyi, G., Kivunike, M., Mugisha, J., Salongo, W., Masembe, S., et al. (2019) Frequency of HIV Status Disclosure, Associated Factors and Outcomes among HIV Positive Pregnant Women at Mbarara Regional Referral Hospital, Southwestern Uganda. The Pan African Medical Journal, 32, Article 200. https://doi.org/10.11604/pamj.2019.32.200.12541
[5]
Izudi, J., Okoboi, S., Lwevola, P., Kadengye, D. and Bajunirwe, F. (2021) Effect of Disclosure of HIV Status on Patient Representation and Adherence to Clinic Visits in Eastern Uganda: A Propensity-Score Matched Analysis. PLOS ONE, 16, e0258745. https://doi.org/10.1371/journal.pone.0258745
[6]
Sendo, E.G., Cherie, A. and Erku, T.A. (2013) Disclosure Experience to Partner and Its Effect on Intention to Utilize Prevention of Mother to Child Transmission Service among HIV Positive Pregnant Women Attending Antenatal Care in Addis Ababa, Ethiopia. BMC Public Health, 13, Article No. 765. https://doi.org/10.1186/1471-2458-13-765
[7]
Stirratt, M.J., Remien, R.H., Smith, A., Copeland, O.Q., Dolezal, C. and Krieger, D. (2006) The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence. AIDS and Behavior, 10, 483-493. https://doi.org/10.1007/s10461-006-9106-6
[8]
FMOH (2003) National HIV/AIDS Counseling Training Manual: Ministry of Health, Disease Prevention and Control Department. Addis Ababa. http://www.moh.gov.et
[9]
Ramadhani, H.O., Thielman, N.M., Landman, K.Z., Ndosi, E.M., Gao, F., Kirchherr, J.L., Shah, R., Shao, H.J., Morpeth, S.C., McNeill, J.D., Shao, J.F., Bartlett, J.A. and Crump, J.A. (2007) Predictors of Incomplete Adherence, Virologic Failure, and Antiviral Drug Resistance among HIV-Infected Adults Receiving Antiretroviral Therapy in Tanzania. Clinical Infectious Diseases, 45, 1492-1498. https://doi.org/10.1086/522991
[10]
Brittain, K., Mellins, C.A., Remien, R.H., Phillips, T.K., Zerbe, A., Abrams, E.J. and Myer, L. (2019) Impact of HIV-Status Disclosure on HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 81, 379-386. https://doi.org/10.1097/QAI.0000000000002036
[11]
Ezechi, O.C., Gab-Okafor, C., Onwujekwe, D.I., Adu, R.A., Amadi, E. and Herbertson, E. (2009) Intimate Partner Violence and Correlates in Pregnant HIV Positive Nigerians. Archives of Gynecology and Obstetrics, 280, 745-752. https://doi.org/10.1007/s00404-009-0956-9
[12]
Sagay, A.S., Musa, J., Ekwempu, C.C., Imade, G.E., Babalola, A., Daniyan, G., Malu, N., Idoko, J.A. and Kanki, P. (2006) Partner Disclosure of HIV Status among HIV-Positive Mothers in Northern Nigeria. African Journal of Medicine and Medical Sciences, 35, 119-123.
[13]
Odiachi, A., Erekaha, S., Cornelius, L.J., et al. (2018) HIV Status Disclosure to Male Partners among Rural Nigerian Women along the Prevention of Mother-to-Child Transmission of HIV Cascade: A Mixed Methods Study. Reproductive Health, 15, Article No. 36. https://doi.org/10.1186/s12978-018-0474-y
[14]
Tam, M., Amzel, A. and Phelps, B.R. (2015) Disclosure of HIV Serostatus among Pregnant and Postpartum Women in Sub-Saharan Africa: A Systematic Review. AIDS Care, 27, 436-450. https://doi.org/10.1080/09540121.2014.997662
[15]
Medley, A., Garcia-Moreno, C., McGill, S. and Maman, S. (2004) Rates, Barriers and Outcomes of HIV Serostatus Disclosure among Women in Developing Countries: Implications for Prevention of Mother-to-Child Transmission Programs. Bulletin of the World Health Organization, 82, 299-307.
[16]
Kennedy, C.E., Haberlen, S., Amin, A., Baggaley, R. and Narasimhan, M. (2015) Safer Disclosure of HIV Serostatus for Women Living with HIV Who Experience or Fear Violence: A Systematic Review. Journal of the International AIDS Society, 18, Article 20292. https://doi.org/10.7448/IAS.18.6.20292
[17]
Colombini, M., James, C., Ndwiga, C., Team, I. and Mayhew, S.H. (2016) The Risks of Partner Violence following HIV Status Disclosure, and Health Service Responses: Narratives of Women Attending Reproductive Health Services in Kenya. Journal of the International AIDs Society, 19, Article 20766. https://doi.org/10.7448/IAS.19.1.20766
[18]
Dankoli, R.S., Aliyu, A.A., Nsubuga, P., Nguku, P., Ossai, O.P., Tukur, D., Ibrahim, L., Madi, J.E., Dalhat, M. and Abdulaziz, M. (2014) HIV Disclosure Status and Factors among Adult HIV Positive Patients in a Secondary Health Facility in North-Eastern Nigeria, 2011. The Pan African Medical Journal, 18, Article 4. https://doi.org/10.11604/pamj.supp.2014.18.1.3551
[19]
Subulade, A., Salami, T. and Adewuyi, G. (2018) Factors That Promote HIV Disclosure among Women Attending Prevention of Mother-to-Child Transmission in a Statein South Nigeria. HIV & AIDS Review. International Journal of HIV-Related Problems, 17, 283-287. https://doi.org/10.5114/hivar.2018.80261
[20]
World Population Review (2023) Abuja Population 2023. https://worldpopulationreview.com/world-cities/abuja-population
[21]
Wikipedia (2023) Abuja Demography. https://en.wikipedia.org/wiki/Abuja#Administration
[22]
Akintola, A., Odutola, M., Olayinka, T., Akinjiola, A., Nwokwu, U.E. and Adebamowo, C. (2021) Cancer in Nigeria. Nigerian National System of Cancer Registries. https://www.ncbi.nlm.nih.gov/books/NBK581073/
[23]
FMOH (2018) Nigeria Demographic and Health Survey.
[24]
FMOH (2018) National HIV/AIDS Indicator and Impact Survey. https://www.naiis.ng/
[25]
FMOH (2023) Health Facility Registry. https://hfr.health.gov.ng/statistics/charts
[26]
Tibebu, N.S., Rade, B.K., Kebede, A.A. and Kassie, B.A. (2023) Disclosure of HIV Status to Sexual Partner and Its Associated Factors among Pregnant Women Living with HIV Attending Prenatal Care in Amhara Regional State Referral Hospitals, Ethiopia. PLOS ONE, 18, e0280045. https://doi.org/10.1371/journal.pone.0280045
[27]
Damian, D.J., Ngahatilwa, D., Fadhili, H., Mkiza, J.G., Mahande, M.J., et al. (2019) Factors Associated with HIV Status Disclosure to Partners and Its Outcomes among HIV-Positive Women Attending Care and Treatment Clinics at Kilimanjaro Region, Tanzania. PLOS ONE, 14, e0211921. https://doi.org/10.1371/journal.pone.0211921
[28]
Bulterys, M.A., Sharma, M., Mugwanya, K., Stein, G., Mujugira, A., Nakyanzi, A., Twohey-Jacobs, L., Ware, N.C., Heffron, R. and Celum, C. (2021) Correlates of HIV Status Nondisclosure by Pregnant Women Living with HIV to Their Male Partners in Uganda: A Cross-Sectional Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 86, 389-395. https://doi.org/10.1097/QAI.0000000000002566
[29]
Alemayehu, M., Aregay, A., Kalayu, A. and Yebyo, H. (2014) HIV Disclosure to Sexual Partner and Associated Factors among Women Attending ART Clinic at Mekelle Hospital, Northern Ethiopia. BMC Public Health, 14, Article 746. https://doi.org/10.1186/1471-2458-14-746
[30]
Viswanathan, S., Justice, A.C., Alexander, G.C., Brown, T.T., Gandhi, N.R., McNicholl, I.R., et al. (2015) Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 69, 493-498. https://doi.org/10.1097/QAI.0000000000000643
[31]
Kobin, A.B. and Sheth, N.U. (2011) Levels of Adherence Required for Virologic Suppression among Newer Antiretroviral Medications. Annals of Pharmacotherapy, 45, 372-379. https://doi.org/10.1345/aph.1P587
[32]
Falang, K.D., Akubaka, P. And Jimam, N.S. (2012) Patient Factors Impacting Antiretroviral Drug Adherence in a Nigerian Tertiary Hospital. Journal of Pharmacology and Pharmacotherapeutics, 3, 138-142.
[33]
Omonaiyea, O., Kusljicb, S., Nicholsona, P., Mohebbia, M. and Manias, E. (2019) Post Option B+ Implementation Programme in Nigeria: Determinants of Adherence of Antiretroviral Therapy among Pregnant Women with HIV. International Journal of Infectious Diseases, 81, 225-230. https://doi.org/10.1016/j.ijid.2019.02.014
[34]
Nyandat, J. and Van Rensburg, G. (2017) Non-Disclosure of HIV-Positive Status to a Partner and Mother-to-Child Transmission of HIV: Evidence from a Case-Control Study Conducted in a Rural County in Kenya. Southern African Journal of HIV Medicine, 18, a691. https://doi.org/10.4102/sajhivmed.v18i1.691
[35]
Torpey, K., Kabaso, M., Weaver, M.A., Kasonde, P., Mukonka, V., Bweupe, M., Mukundu, J. and Mandala, J. (2012) Infant Feeding Options, Other Nonchemoprophylactic Factors, and Mother-to-Child Transmission of HIV in Zambia. Journal of International Association of Physicians in AIDS Care (JIAPAC), 11, 26-33. https://doi.org/10.1177/1545109710393308
